Moloney Securities Asset Management’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-42,866
| Closed | -$204K | – | 504 |
|
|
2025
Q1 | $204K | Sell |
42,866
-44,933
| -51% | -$214K | 0.03% | 431 |
|
|
2024
Q4 | $335K | Buy |
87,799
+56,100
| +177% | +$214K | 0.04% | 328 |
|
|
2024
Q3 | $284K | Sell |
31,699
-17,500
| -36% | -$157K | 0.04% | 371 |
|
|
2024
Q2 | $479K | Sell |
49,199
-5,000
| -9% | -$48.7K | 0.07% | 275 |
|
|
2024
Q1 | $735K | Buy |
54,199
+24,524
| +83% | +$333K | 0.11% | 206 |
|
|
2023
Q4 | $325K | Buy |
29,675
+8,292
| +39% | +$90.8K | 0.05% | 323 |
|
|
2023
Q3 | $219K | Buy |
21,383
+10,983
| +106% | +$112K | 0.04% | 366 |
|
|
2023
Q2 | $164K | Sell |
10,400
-6,967
| -40% | -$110K | 0.03% | 384 |
|
|
2023
Q1 | $393K | Sell |
17,367
-2,216
| -11% | -$50.1K | 0.07% | 267 |
|
|
2022
Q4 | $699K | Sell |
19,583
-1,500
| -7% | -$53.6K | 0.15% | 179 |
|
|
2022
Q3 | $822K | Buy |
21,083
+3,110
| +17% | +$121K | 0.2% | 137 |
|
|
2022
Q2 | $863K | Buy |
17,973
+2,433
| +16% | +$117K | 0.2% | 135 |
|
|
2022
Q1 | $1.44M | Buy |
15,540
+3,301
| +27% | +$305K | 0.28% | 102 |
|
|
2021
Q4 | $2.72M | Sell |
12,239
-265
| -2% | -$58.8K | 0.46% | 49 |
|
|
2021
Q3 | $4.33M | Buy |
12,504
+433
| +4% | +$150K | 0.79% | 27 |
|
|
2021
Q2 | $4.53M | Sell |
12,071
-1,710
| -12% | -$642K | 0.83% | 24 |
|
|
2021
Q1 | $4.28M | Buy |
13,781
+2,381
| +21% | +$739K | 0.84% | 28 |
|
|
2020
Q4 | $2.85M | Buy |
11,400
+3,383
| +42% | +$846K | 0.63% | 41 |
|
|
2020
Q3 | $1.48M | Buy |
8,017
+2,799
| +54% | +$517K | 0.39% | 79 |
|
|
2020
Q2 | $1.3M | Buy |
5,218
+1,485
| +40% | +$371K | 0.38% | 86 |
|
|
2020
Q1 | $675K | Buy |
3,733
+2,761
| +284% | +$499K | 0.24% | 112 |
|
|
2019
Q4 | $405K | Buy |
+972
| New | +$405K | 0.13% | 201 |
|